Clinical Trial: Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease

Brief Summary: This is a study to determine if oral arginine will increase nitric oxide in sickle cell disease (SCD) patients with acute chest syndrome (ACS). It will also assess the effects of arginine in the body and how the body uses nitric oxide in ACS.